Erfan Hospital Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2007
NCT00676377
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Dr. Erfan and Bagedo General Hospital

Active Ingredients

Drugs in Phase 4 Trials (2)

neostigmine (bloxiverz) (1 trial)

sodium chloride (2 trials)

Drugs in Phase 2 Trials (1)

remifentanil (ultiva) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ileus (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3